Solving Data Management Challenges with Strategic CRO Oversight

Sponsors occasionally face unexpected hurdles with their data management vendors —missed timelines, inconsistent data quality, and inefficient workflows.

These challenges can delay critical milestones like database lock and compromise the integrity of clinical trial data.

In a recent analysis of clinical trial costs conducted by Tufts CSDD, a Phase III clinical trial spends, on average, $55,716 per day in direct costs. When issues are identified early, sponsors can get vendors back on track and back on time through data management CRO oversight, potentially saving hundreds of thousands of dollars in costs due solely to inefficient operational strategies.

We spoke with a PharPoint Data Management consultant who regularly partners with sponsors to provide this oversight, and she discussed three common findings.

One

Your data management CRO isn’t fully leveraging technology.

One common challenge is an over-reliance on manual processes for data cleaning. Manual review can introduce inefficiencies and increase the risk of errors, as humans are naturally prone to oversight.

At PharPoint, most of our data cleaning tasks are supported by SAS programming. This allows for faster, higher-quality processing of large datasets and reduces the risk of human error.

Another contributing factor to poor technology adoption can be insufficient training for data coordinators. Without exposure to advanced tools or techniques – such as SAS or enhanced Excel functionality – team members may not realize what is possible beyond manual review. Comprehensive training and a collaborative team can help bridge this gap.

Two

Your data management CRO is waiting until database lock to conduct 90% of the data cleaning.

Another key observation is the tendency of data management teams to lag behind in data cleaning efforts until the database lock stage. When the majority of cleaning happens at the end of a study, it creates bottlenecks for all stakeholders — data managers, CRAs, and site staff.

Early and ongoing cleaning throughout the study lifecycle helps maintain data quality, reduces last-minute surprises, and ensures a smoother path to database lock. Ultimately, this approach helps teams supports timely deliverables with the highest data quality, whether for interim analyses, regulatory submission requirements or final database lock.

Three

Your data management CRO doesn’t collaborate with their biostatistics team.

Data Management and Biostatistics often operate as separate functions, yet their work is highly interconnected. Early collaboration with biostatisticians can provide data managers with valuable context and prevent downstream challenges post-database lock.

In one recent example of this cross-functional teamwork in action, the PharPoint data management team was determining how to best report a complex screen failure situation. The team held discussions with the biostatistician to help brainstorm, who was able to inform on which potential data entry solutions under consideration would impact final analysis outputs. What the data management team was considering as the leading option was ultimately decided against with the input from the biostatistical perspective.

This type of casual collaboration and integration across functions helps data managers proactively make informed decisions while keeping statistical endpoints in mind.

Partnering for Better Outcomes

There are many reasons why a sponsor may choose to engage a Data Management CRO Oversight partner, from addressing technology gaps to ensuring consistent quality and operational efficiency.

Regardless of current concerns, sponsors do not have to navigate these challenges alone. PharPoint’s data management consultants provide strategic oversight, guidance, and plans to help strengthen vendor performance, improve data currency, and accelerate timelines.

To learn more about our data management CRO oversight support solutions, reach out to our team.


RELATED RESOURCES

Key Interactions Between Biometrics Teams for a More Efficient Clinical Trial

Key Interactions Between Biometrics Teams for a More Efficient Clinical Trial

Discover key interactions between clinical data management and biostatistics teams for a more efficient clinical trial.
A Review of the 2024 Draft Guidance for DMCs

A Review of the 2024 Draft Guidance for DMCs

In early 2024, FDA released an updated draft guidance for data monitoring committees (DMCs).
Exploring the Characteristics of a High-Performing Medical Writing Vendor

Exploring the Characteristics of a High-Performing Medical Writing Vendor

What characteristics should you look for in your medical writing partner? We spoke with PharPoint's Associate Director of Medical Writing, Samia, to learn more.
How to Select Data Monitoring Committee (DMC) Members

How to Select Data Monitoring Committee (DMC) Members

Working to select members for a data monitoring committee? Explore criteria for member selection, training, and how to select a Chairperson.
The History of Data Monitoring Committees

History of Data Monitoring Committees

Learn more about the evolution and history of data monitoring committees, from the 1960s to today.
The Journey of Clinical Trial Data Points: From Patient to TLFs

The Journey of Clinical Trial Data Points: From Patient to TLFs

Learn more about the journey clinical trial data takes before ending up on the package insert of a drug you're taking.
Written by: Theresa Hegar